Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Zacks Strategist Shaun Pruitt Discusses the Surge in Robinhood’s Stock 3 Zacks Strong Buy Growth Stocks for Your Short List